The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Hyperandrogenism Accompanies Increased Intra-Abdominal Fat Storage in Normal Weight Polycystic Ovary Syndrome Women
Open accessAbstract
CONTEXT: Normal weight polycystic ovary syndrome (PCOS) women may have altered adipose structure-function underlying metabolic dysfunction. OBJECTIVE: This study examines whether adipose structure-functional changes exist in normal weight PCOS women and correlate with hyperandrogenism and/or hyperinsulinemia. DESIGN: This is a prospective cohort study. SETTING: The setting was an academic medical center. PATIENTS: Six normal weight PCOS women and 14 age- and body mass index-matched normoandrogenic ovulatory (NL) women were included. INTERVENTION(S): All women underwent circulating hormone and metabolic measurements; frequently sampled intravenous glucose tolerance testing; total body dual-energy x-ray absorptiometry; abdominal magnetic resonance imaging; and SC abdominal fat biopsy. MAIN OUTCOME MEASURE(S): Circulating hormones and metabolites, body fat and its distribution, and adipocyte size were compared between PCOS and NL women, and were correlated with each other in all women. RESULTS: Circulating LH and androgen levels were significantly greater in PCOS than NL women, as were fasting insulin levels, pancreatic β-cell responsiveness to glucose, and total abdominal fat mass. Intra-abdominal fat mass also was significantly increased in PCOS women and was positively correlated with circulating androgen, fasting insulin, triglyceride, and non-high-density lipoprotein cholesterol levels in all women. SC abdominal fat mass was not significantly increased in PCOS women, but contained a greater proportion of small SC abdominal adipocytes that positively correlated with serum androgen levels in all women. CONCLUSION: Hyperandrogenism in normal weight PCOS women is associated with preferential intra-abdominal fat deposition and an increased population of small SC abdominal adipocytes that could constrain SC adipose storage and promote metabolic dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In PCOS women, COCs can improve the clinical and biochemical picture of hyperandrogenism and some metabolic aspects such as alterations in cholesterol and fat distribution [62], but they can also cause side effects that must be considered, especially in PCOS women with metabolic and cardiovascular risk factors [63].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [62]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biometry: The Principles and Practice of Statistics in Biological Research
Sokal, R. R., & Rohlf, F. J. (1969) · Cited by 20,963
Biometry. The Principles and Practice of Statistics in Biological Research
Fienberg, S. E., Sokal, R. R., Rohlf, F. J., Rohlf, F. J., & Sokal, R. R. (1970) · Biometrics · doi:10.2307/2529087 · Cited by 9,363
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,759
Knochenhauer, E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.9.3078 · Cited by 1,134
Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020
Self-citationAdipose tissue expandability, lipotoxicity and the Metabolic Syndrome — An allostatic perspective
Virtue, S., & Vidal-Puig, A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.12.006 · Cited by 1,013
Lim, S. S., Davies, M. J., Norman, R. J., & Moran, L. J. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms030 · Cited by 939
Stepto, N. K., Cassar, S., Joham, A. E., Hutchison, S. K., Harrison, C. L., Goldstein, R. F., & Teede, H. J. (2013) · Human Reproduction · doi:10.1093/humrep/des463 · Cited by 747
Flagged first, then by citations
Research works printed but not linked: 1
- Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tol- erance, type 2 diabetes and metabolic syndrome: a systemic review and meta-analysis. Hum Reprod Updates. 2010;16:347-363.
Cited by
Sorted by citations
Items 101–200 of 218
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
Xue, P., Wang, Z., Fu, X., Wang, J., Punchhi, G., Wolfe, A., & Wu, S. (2018) · Journal of Visualized Experiments · doi:10.3791/58379 · Cited by 18
Ożegowska, K., Bartkowiak-Wieczorek, J., Bogacz, A., Seremak‐Mrozikiewicz, A., Dulęba, A. J., & Pawelczyk, L. A. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1695248 · Cited by 18
Dumesic, D. A., Turcu, A. F., Liu, H., Grogan, T., Abbott, D. H., Lu, G., Dharanipragada, D., & Chazenbalk, G. D. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad079 · Cited by 20
Self-citationAdipose-androgen crosstalk in polycystic ovary syndrome: mechanisms and therapeutic implications
Ni, M., Lei, H., Ye, T., & Wang, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1731179 · Cited by 25
Endoplasmic Reticulum Stress: A New Research Direction for Polycystic Ovary Syndrome?
Wang, C., & Zhang, Y. (2022) · DNA and Cell Biology · doi:10.1089/dna.2021.1050 · Cited by 18
Hamid, F. A., Abu, M., Karim, A. K. A., Ahmad, M., Aziz, N. A., Kamal, D. A. M., & Mokhtar, M. H. (2022) · Biomedicines · doi:10.3390/biomedicines10071705 · Cited by 17
An Evolutionary Model for the Ancient Origins of Polycystic Ovary Syndrome
Dumesic, D. A., Abbott, D. H., & Chazenbalk, G. D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12196120 · Cited by 17
Self-citationDumesic, D. A., Tulberg, A., McNamara, M. A., Grogan, T., Abbott, D. H., Naik, R., Lu, G., & Chazenbalk, G. D. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab158 · Cited by 17
Self-citationKey signalling pathways underlying the aetiology of polycystic ovary syndrome
Walters, K. A., Moreno-Asso, A., Stepto, N. K., Pankhurst, M. W., Paris, V. R., & Rodgers, R. J. (2022) · Journal of Endocrinology · doi:10.1530/joe-22-0059 · Cited by 19
Oğuz, S. H., İdilman, İ. S., Helvacı, N., Guzelce, E. C., Eyüpoğlu, D., Karçaaltıncaba, M., & Yıldız, B. O. (2020) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2020.04.024 · Cited by 16
The Role of Peroxisome Proliferator-Activated Receptors in Polycystic Ovary Syndrome
Psilopatis, I., Vrettou, K., Nousiopoulou, E., Palamaris, K., & Theocharis, S. E. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12082912 · Cited by 16
Colonetti, L., Grande, A. J., Becker, I. R. T., Ceretta, L. B., da Rosa, M. I., & Colonetti, T. (2022) · Nutrition Research · doi:10.1016/j.nutres.2022.03.009 · Cited by 17
Joham, A. E., Rees, A., Shinkai, K., Forslund, M., Tay, C. T., & Teede, H. J. (2025) · Reproduction · doi:10.1530/rep-25-0121 · Cited by 13
Cavalcante, R. B. D. M., Leão, L. M. C. S. M., Tavares, A. B. W., Lopes, K. G., & Kraemer‐Aguiar, L. G. (2024) · Hormone and Metabolic Research · doi:10.1055/a-2386-9281 · Cited by 13
Can polyunsaturated fatty acids regulate Polycystic Ovary Syndrome via TGF-β signalling?
Prabhu, Y. D., & Gopalakrishnan, A. V. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119416 · Cited by 15
Body Composition and Its Impact on the Hormonal Disturbances in Women with Polycystic Ovary Syndrome
Bizoń, A., Płaczkowska, S., Niepsuj, J., Czwojdzińska, M., Leśniewski, M., Nowak, A., Pluta, D., Madej, P., Piwowar, A., & Franik, G. (2021) · Nutrients · doi:10.3390/nu13124217 · Cited by 13
Tohma, Y. A., Önalan, G., Tepeoğlu, M., Bayraktar, N., Çolak, E., Özçimen, E. E., & Zeyneloğlu, H. B. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7428 · Cited by 12
The emerging role of the gut microbiome in polycystic ovary syndrome
He, Y., Jin, X., Wang, H., Dai, H., Lu, X., Zhao, J., Zhang, H., Chen, W., & Wang, G. (2021) · F&S Reviews · doi:10.1016/j.xfnr.2021.03.003 · Cited by 14
Alalami, H., Sathyapalan, T., & Atkin, S. L. (2018) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018818805674 · Cited by 12
Sex Differences in the Impact of Obesity on Immunity
Vijayakumar, S., Pantha, S., Magar, S. B., & Dhakal, S. (2026) · Immunological Reviews · doi:10.1111/imr.70101 · Cited by 10
Dumesic, D. A., Padmanabhan, V., & Abbott, D. H. (2025) · Reproduction · doi:10.1530/rep-25-0021 · Cited by 11
Self-citationÇelik, Ö., Yazıcı, D., Ciudin, A., Macut, D., Micić, D., Yumuk, V., & Yıldız, B. O. (2025) · Obesity Facts · doi:10.1159/000547055 · Cited by 13
On the Intimate Relationship of Adiposity to Polycystic Ovary Syndrome
Rosenfield, R. L., & Dumesic, D. A. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf527 · Cited by 11
Self-citationRashid, A., Ganie, M. A., Wani, I. A., Bhat, G. A., Shaheen, F., Wani, I. A., Shrivastava, M., & Shah, Z. A. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1084-5441 · Cited by 9
Dumesic, D. A., Rasouli, M. A., Katz, J. D., Lu, G., Dharanipragada, D., Turcu, A. F., Grogan, T., Flores, K., Magyar, C. E., Abbott, D. H., et al. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae162 · Cited by 9
Self-citationTian, Y., Wang, A., Li, F., Wang, S., Jie, S., Zhang, K., & Bai, X. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01711-5 · Cited by 8
The impact of obesity and lipids on cancer: Insights into mechanisms and potential interventions
Romero, M., Lian, Y., Piquer, A., Borràs-Ferré, N., Antonio Zorzano, A., & Ivanova, S. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.07.006 · Cited by 8
Defining PCOS: A syndrome with an intrinsic heterogeneous nature
Escobar-Morreale, H. F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00012-2 · Cited by 8
General infertility workup in times of high assisted reproductive technology efficacy
Polyzos, N. P., Ayoubi, J. M., & Pirtea, P. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.05.019 · Cited by 8
Kogure, G. S., Ribeiro, V. B., Mendes, M. C., Ferriani, R. A., Furtado, C. L. M., & dos Reis, R. M. (2023) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000627 · Cited by 8
Circulating neuregulin-1 levels in polycystic ovary syndrome
Arpacı, H. (2019) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2018.1519530 · Cited by 9
Unraveling PCOS therapies: Pharmacotherapeutic strategies and emerging therapeutic targets
Shirasath, K. R., Ahmed, N. Z., Kumar, P., Alam, S., Karwasra, R., Goyal, S. N., & Agrawal, Y. O. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156245 · Cited by 7
Cavalcante, R. B. D. M., Leão, L. M. C. S. M., Tavares, A. B. W., Lopes, K. G., Terra, C., Salgado, Â. A., & Kraemer‐Aguiar, L. G. (2024) · Endocrine · doi:10.1007/s12020-024-04077-8 · Cited by 9
Cai, M., Gao, J., Du, L., Cheng, X., Zhou, D., Zhu, J., Qu, S., & Zhang, M. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05496-6 · Cited by 7
Developmental origins of polycystic ovary syndrome: Everything starts in utero
Abbott, D. H., Greinwald, E. P., & Levine, J. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00009-2 · Cited by 9
Self-citationLifestyle Changes and Weight Loss: Effects in PCOS
Ionescu, C. A., Popescu, I., Banacu, M., & Dimitriu, M. C. T. (2018) · InTech eBooks · doi:10.5772/intechopen.73298 · Cited by 7
Alaee, S., Ekramzadeh, M., Samare‐Najaf, M., Jahromi, B. N., Shokri, S., Ghomashi, F., & Hooshmandi, H. (2024) · Journal of Infertility and Reproductive Biology · doi:10.18502/jirb.v12i4.17975 · Cited by 6
Wu, X., Yi, W., & Liu, X. (2026) · Biomedicines · doi:10.3390/biomedicines14010213 · Cited by 6
Reich, L. A., Fleur, R. G. S., Gjelsvik, A., Field, A. E., & Ziobrowski, H. N. (2025) · Human Reproduction · doi:10.1093/humrep/deae294 · Cited by 6
Kara, Ö., Kaymaz, N., & Uzun, M. E. (2022) · Archives of Women s Mental Health · doi:10.1007/s00737-022-01264-2 · Cited by 6
Rozati, R. (2021) · Journal of Gynecology and Womens Health · doi:10.19080/jgwh.2021.21.556069 · Cited by 7
Kabakchieva, P., GATEVA, A., Velikova, T. V., Georgiev, T., & KAMENOV, Z. (2022) · Minerva Endocrinology · doi:10.23736/s2724-6507.21.03336-4 · Cited by 6
Li, L., Ma, J., Sun, N., Hu, P., Lin, Y., & Zhang, Q. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-00955-8 · Cited by 5
Androgen actions in metabolic tissues in polycystic ovary syndrome
MacRae, C. L., & Campbell, R. E. (2026) · Endocrinology · doi:10.1210/endocr/bqag001 · Cited by 5
Insight into the pathogensis of polycystic ovarian syndrome
Jung, Y. W., Lee, G. H., Han, Y. J., & Cha, D. H. (2020) · Journal of genetic medicine · doi:10.5734/jgm.2020.17.1.1 · Cited by 5
Lin, R., Zheng, S., Su, H., Wang, G., Li, X., & Lu, C. (2024) · Phenomics · doi:10.1007/s43657-024-00183-9 · Cited by 5
Abdelhameed, A. M., Eissa, M., Thompson, K., Edwards, K. S., Hoang, N., Rezq, S., Cornelius, D. C., Romero, D. G., & Cardozo, L. L. Y. (2025) · Endocrinology · doi:10.1210/endocr/bqaf173 · Cited by 4
Evaluation of Insulin Resistance Measurement Methods in Patients with Polycystic Ovary Syndrome
Bilginer, M. C., Tüfekçi, D., Günay, Y., Usta, O., Coşkun, H., Üçüncü, Ö., Nuhoğlu, İ., & Koçak, M. (2022) · Turkish Journal of Diabetes and Obesity · doi:10.25048/tudod.1041387 · Cited by 7
Pan, Q., Chen, M., Zhang, R.-N., Wang, Y.-Q., Zheng, R.-D., Mi, Y., Liu, W., Shen, F., Su, Q., & Fan, J. (2017) · Journal of Diabetes Research · doi:10.1155/2017/4740124 · Cited by 5
Hu, Y., Chen, B., Pan, Y., Xing, K., Xiao, Z., Sheng, B., Li, J., Dong, H., & Lv, F. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1374718 · Cited by 4
Pesonen, E., Nurkkala, M., Ollila, M., Hurskainen, E., Morin-Papunen, L. C., Jämsä, T. J., Korpelainen, R., Niemelä, M., & Piltonen, T. (2024) · Fertility and Sterility · doi:10.1016/j.fertnstert.2024.09.042 · Cited by 7
The Endocrinological Basis for Polycystic Ovary Syndrome: An Evolutionary Perspective
Dumesic, D. A., Crespi, B. J., Padmanabhan, V., & Abbott, D. H. (2025) · Endocrinology · doi:10.1210/endocr/bqaf160 · Cited by 4
Self-citationInsights Gained From Marmoset Endocrine Research
Kraynak, M., Levine, J. E., & Abbott, D. H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811829-0.00029-7 · Cited by 4
Self-citationPolycystic ovary syndrome in adolescence: Toward a better diagnosis and treatment
Evans, A. T., & Hoeger, K. M. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.04.010 · Cited by 4
Relationship between Polycystic Ovary Syndrome and Metabolic Syndrome
Saldívar-Cerón, H. I. (2023) · The Journal of Reproduction · doi:10.58779/issn.2954-467x.tjor2023.v2.n1.15 · Cited by 4
Interface between reproductive and metabolic dysfunction in polycystic ovary syndrome
Rasouli, M. A., Katz, J., & Dumesic, D. A. (2025) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000001037 · Cited by 5
Self-citationEscalona, X. A., Ayala, R., Cortez, K. L., Sánchez, S. F., Tomé-Dehesa, T., Díaz-Hernández, V., Larqué, C., & Escalona, R. (2025) · Biology · doi:10.3390/biology14060592 · Cited by 3
Noguchi, H., Yamamoto, Y., Arata, M., Nakamura, N., Yamanaka, E., Tamura, K., Aoki, H., Takeda, A., Minato, S., Inui, H., et al. (2025) · Journal of Endocrinology · doi:10.1530/joe-24-0348 · Cited by 3
Ghosh, A., Kar, T. K., Sil, S., Barman, A., & Chattopadhyay, S. (2025) · Macedonian Veterinary Review · doi:10.2478/macvetrev-2025-0026 · Cited by 3
NAD+ sensing by PARP7 regulates the C/EBPβ-dependent transcription program during adipogenesis
Stokes, M. S., Kim, Y. J., Kim, Y., Koul, S., Chiu, S.-P., Liu, C., Dasovich, M., Zuniga, J., Nandu, T. S., Huang, D., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.116929 · Cited by 5
Pinton, P. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1787902 · Cited by 3
Precision Nutrition in Female Reproductive Health
Dumesic, D. A., Chazenbalk, G. D., & Heber, D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15315-0.00002-x · Cited by 3
Self-citationHuang, M.-C., Chen, P., & Hsu, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147948 · Cited by 3
Shan, C., Yu, J., Zhu, Y., Zhao, J., Wang, L., Li, Y.-S., Lin, S.-Y., Liu, W., Lü, Q., & Tao, T. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf272 · Cited by 4
Ishaq, S., Rizwani, G. H., Fatima, S., Shareef, H., Anser, H., & Jamil, S. (2022) · Research Square · doi:10.21203/rs.3.rs-1371836/v1 · Cited by 3
Haapakangas, S. M., Koskenkari, N. V. S., Hurskainen, E., Arffman, R. K., Ollila, M., & Piltonen, T. (2025) · International Journal of Obesity · doi:10.1038/s41366-025-01753-1 · Cited by 2
Mao, D., Wei, Y., Wang, C., & Tao, J. (2026) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-026-08344-z · Cited by 2
Weidner, A. E., Vann, K., Hodowanec, A. I., Ivey, D., Roy, A., Sechrist, Z. R., Cole, C. L., & Astapova, O. (2026) · Endocrinology · doi:10.1210/endocr/bqag025 · Cited by 2
de Medeiros, S. F., & Maciel, G. A. R. (2026) · Metabolites · doi:10.3390/metabo16060393 · Cited by 3
Non-contraceptive Benefits of Hormonal Methods
Seracchioli, R., Forno, S. D., & Esposti, E. D. (2021) · Trends in andrology and sexual medicine · doi:10.1007/978-3-030-70932-7_10 · Cited by 3
The pathogenic role of androgen excess in PCOS
Pignatelli, D., Pereira, S. S., & Kandaraki, E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00017-1 · Cited by 4
Intergenerational Implications of PCOS
Willging, M. M., Abbott, D. H., & Dumesic, D. A. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_27 · Cited by 2
Self-citationLi, X., Li, Y., Zhang, B., Wang, J., Yang, Y., & Du, Y. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01647-w · Cited by 2
Proinflammatory Cytokines in Women with PCOS in Atypical Pathogen Infections
Chudzicka-Strugała, I., Gołębiewska, I., Brudecki, G. P., Elamin, W. F., Banaszewska, B., Chudzicka-Adamczak, M., Strugała, D., & Zwoździak, B. (2025) · Diagnostics · doi:10.3390/diagnostics15131669 · Cited by 3
The multifarious role of insulin in PCOS: From pathophysiology to therapeutic management
Moghetti, P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00002-x · Cited by 2
Yavuz, A., Uğur, K., Karagöz, Z. K., Ayan, D., & Aydın, S. (2022) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog4904087 · Cited by 2
Татарчук, Т. Ф., Tutchenko, T. М., & Бурка, О. А. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.103808 · Cited by 2
Effect of Educational Program on Quality of Life among Women with Polycystic Ovarian Syndrome
(2021) · Egyptian Journal of Nursing and Health Sciences · doi:10.21608/ejnhs.2021.234369 · Cited by 3
Role of vitamin D and insulin resistance in polycystic ovary syndrome
Abdallah, A., El-Azab, G. A., Mosbeh, M., & Sarhan, H. A. (2021) · Journal of advanced Biomedical and Pharmaceutical Sciences · doi:10.21608/jabps.2021.70702.1125 · Cited by 2
Ishaq, S., Rizwani, G. H., Fatima, S., Shareef, H., Anser, H., & Jamil, S. (2022) · Research Square · doi:10.21203/rs.3.rs-1371836/v2 · Cited by 2
Stokes, M. S., Kim, Y. J., Kim, Y., Koul, S., Chiu, S.-P., Dasovich, M., Zuniga, J., Nandu, T. S., Huang, D. Y., Mathews, T. P., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.07.647692 · Cited by 2
Wongwananuruk, T., Kongcharoensukying, A., Pramyothin, P., Indhavivadhana, S., Tanmahasamut, P., Rattanachaiyanont, M., Techatraisak, K., Angsuwathana, S., Sa‐nga‐areekul, N., Pingkul, N., et al. (2024) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5102052 · Cited by 1
Impact of substance abuse on polycystic ovarian syndrome
Ajayi, L. O., Onaolapo, M. C., Akanbi, G. B., Ayodele, A. H., Alabi, M. O., Gbenga, G. O., Akano, O. P., & Ajayi, A. F. (2025) · Discover Endocrinology and Metabolism · doi:10.1007/s44417-025-00004-1 · Cited by 1
Zaidieva, Y. Z., Balan, V. E., & Tsar’kova, A. V. (2023) · Russian Bulletin of Obstetrician-Gynecologist · doi:10.17116/rosakush20232306125 · Cited by 2
Гончарова, О. А., Архипкіна, Т., & Любимова, Л. (2022) · PROBLEMS OF ENDOCRINE PATHOLOGY · doi:10.21856/j-pep.2022.2.15 · Cited by 1
INFLAMMATORY GENE EXPRESSION IN WOMEN DIAGNOSED WITH POLYCYSTIC OVARIAN SYNDROME
Taylor, M. K. (2016) · Pittsburg State University Digital Commons (Pittsburg State University)
Bakır, V. L., & Karahan, G. (2019) · Zeynep Kamil Tıp Bülteni · doi:10.16948/zktipb.558143
Ribeiro, V. B. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2019.tde-01022019-101328
Androgen Receptors in the Pathology of Disease
Leung, J. K., Tien, A. H., & Sadar, M. D. (2021) · Springer eBooks · doi:10.1007/978-3-030-78315-0_16
A COMPARATIVE STUDY OF INSULIN RESISTANCE IN PATIENTS OF POLYCYSTIC OVARY SYNDROME
Arif, A., Waheed, P., Anees, R., Rashid, A., & Khan, S. A. (2021) · Pakistan Armed Forces Medical Journal · doi:10.51253/pafmj.v71i5.2633
Management of PCOS Women Preparing Pregnancy
Ruan, X., & Mueck, A. O. (2021) · ISGE series · doi:10.1007/978-3-030-63650-0_11
Rodgers, R., & Hummitzsch, K. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733232135.793546087
Selvanesan, B. C., & Chappell, N. R. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733232135.793546184
POLİKİSTİK OVER SENDROMU FENOTİPLERİ VE METABOLİK DİSFONKSİYON İLİŞKİSİ
Osmanlıoğlu, Ş., & Omma, T. (2023) · İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi · doi:10.33715/inonusaglik.1215455
Ezugwu, E. E., Ugwu, A. C., Manafa, P. O., EZUGWU, I. G., & Ogolodom, M. P. (2022) · International Journal of Applied Science and Research · doi:10.56293/ijasr.2022.5490
Inositol and herbal substances as elements of complementary therapy in patients with PCOS
Aab, A., Zarańska, J., Kędra, K., MICHALIK, I., Bielak, M., & Zarański, B. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.16.01.012
Current perspectives on the metabolic aspects of polycystic ovary syndrome
Korchynska, O. O., Khashcha, I. I., & Shumilina, T. (2023) · Reproductive health of woman · doi:10.30841/2708-8731.8.2023.297796
Polycystic Ovarian Disease Associated with Adolescent Lifestyles
Singh, S., Nishad, V., Johri, P., Pandey, R., & Trivedi, M. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815274431124010015
Khan, M. R. (2024) · African Journal of Biomedical Research · doi:10.53555/ajbr.v27i4s.4663
Zhang, Y., Zhou, W., Su, Q., & Chen, Q. (2025) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/0113862073325251241101054306
Metadata
- Authors
- Dumesic, D. A., Akopians, A. L., Madrigal, V. K., Ramirez, E., Margolis, D. J., Sarma, M. K., Thomas, A. M., Grogan, T. R., Haykal, R., Schooler, T. A., Okeya, B. L., Abbott, D. H., & Chazenbalk, G. D.
- Affiliations
- University of California, Los Angeles (US)
- University of Wisconsin–Madison (US)
- Corresponding author
- Dumesic, Daniel A.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-11
- Volume
- 101
- Issue
- 11
- Pages
- 4178-4188
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC5095243
- OpenAlex
- W2514157066
- Cited by
- 222
- References
- 59
- Citations by year
- 2026: 20 · 2025: 29 · 2024: 15 · 2023: 20 · 2022: 28 · 2021: 25 · 2020: 24 · 2019: 25 · 2018: 18 · 2017: 17 · 2016: 1
- FWCI
- 26.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (UL1TR000124, P51OD011092)
- National Center for Advancing Translational Sciences
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD071836)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- polycystic ovary syndrome, hyperandrogenism, intra-abdominal fat, abdominal fat, subcutaneous adipocytes, adipocyte size, hyperinsulinemia, insulin resistance, beta-cell function, luteinizing hormone, metabolic dysfunction, normal-weight women
- MeSH terms
- Adolescent, Adult, Body Weight, Female, Humans, Polycystic Ovary Syndrome, Prospective Studies, Hyperandrogenism, Intra-Abdominal Fat, Subcutaneous Fat, Abdominal, Adipocytes, White, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
